BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 1378020)

  • 1. T cell clones with normal or defective O-galactosylation from a patient with permanent mixed-field polyagglutinability.
    Thurnher M; Clausen H; Fierz W; Lanzavecchia A; Berger EG
    Eur J Immunol; 1992 Jul; 22(7):1835-42. PubMed ID: 1378020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent repression of a functional allele can be responsible for galactosyltransferase deficiency in Tn syndrome.
    Thurnher M; Rusconi S; Berger EG
    J Clin Invest; 1993 May; 91(5):2103-10. PubMed ID: 7683697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tn antigen and UDP-Gal:GalNAc alpha-R beta 1-3Galactosyltransferase expression in human breast carcinoma.
    Zhuang D; Yousefi S; Dennis JW
    Cancer Biochem Biophys; 1991 Nov; 12(3):185-98. PubMed ID: 1844911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.
    Kjeldsen T; Clausen H; Hirohashi S; Ogawa T; Iijima H; Hakomori S
    Cancer Res; 1988 Apr; 48(8):2214-20. PubMed ID: 2450649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric analysis of erythrocyte populations in Tn syndrome blood using monoclonal antibodies to glycophorin A and the Tn antigen.
    Bigbee WL; Langlois RG; Stanker LH; Vanderlaan M; Jensen RH
    Cytometry; 1990; 11(2):261-71. PubMed ID: 1690628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbohydrate recognition factors of a Talpha (Galbeta1-->3GalNAcalpha1-->Ser/Thr) and Tn (GalNAcalpha1-->Ser/Thr) specific lectin isolated from the seeds of Artocarpus lakoocha.
    Singh T; Chatterjee U; Wu JH; Chatterjee BP; Wu AM
    Glycobiology; 2005 Jan; 15(1):67-78. PubMed ID: 15329360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats.
    Hanisch FG; Stadie T; Bosslet K
    Cancer Res; 1995 Sep; 55(18):4036-40. PubMed ID: 7545084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies and synthetic tumor-associated glycoconjugates in the study of the expression of Thomsen-Friedenreich-like and Tn-like antigens on human cancers.
    Longenecker BM; Willans DJ; MacLean GD; Selvaraj S; Suresh MR; Noujaim AA
    J Natl Cancer Inst; 1987 Mar; 78(3):489-96. PubMed ID: 3469463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosyltransferase changes upon differentiation of CaCo-2 human colonic adenocarcinoma cells.
    Brockhausen I; Romero PA; Herscovics A
    Cancer Res; 1991 Jun; 51(12):3136-42. PubMed ID: 1904002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutively hyposialylated human T-lymphocyte clones in the Tn-syndrome: binding characteristics of plant and animal lectins.
    Mrkoci K; Kelm S; Crocker PR; Schauer R; Berger EG
    Glycoconj J; 1996 Aug; 13(4):567-73. PubMed ID: 8872113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human urinary bladder carcinoma glycoconjugates expressing T-(Gal beta(1-3)GalNAc alpha 1-O-R) and T-like antigens: a comparative study using peanut agglutinin and poly- and monoclonal antibodies.
    Langkilde NC; Wolf H; Clausen H; Orntoft TF
    Cancer Res; 1992 Sep; 52(18):5030-6. PubMed ID: 1516058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer.
    Itzkowitz SH; Yuan M; Montgomery CK; Kjeldsen T; Takahashi HK; Bigbee WL; Kim YS
    Cancer Res; 1989 Jan; 49(1):197-204. PubMed ID: 2908846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin.
    Campbell BJ; Finnie IA; Hounsell EF; Rhodes JM
    J Clin Invest; 1995 Feb; 95(2):571-6. PubMed ID: 7860740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential binding properties of Gal/GalNAc specific lectins available for characterization of glycoreceptors.
    Wu AM; Song SC; Sugii S; Herp A
    Indian J Biochem Biophys; 1997; 34(1-2):61-71. PubMed ID: 9343930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyvalent GalNAcalpha1-->Ser/Thr (Tn) and Galbeta1-->3GalNAcalpha1-->Ser/Thr (T alpha) as the most potent recognition factors involved in Maclura pomifera agglutinin-glycan interactions.
    Wu AM
    J Biomed Sci; 2005; 12(1):135-52. PubMed ID: 15864746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tn epitopes, immunoreactive with ordinary anti-Tn antibodies, on normal, desialylated human erythrocytes and on Thomsen-Friedenreich antigen isolated therefrom.
    Springer GF; Desai PR
    Mol Immunol; 1985 Nov; 22(11):1303-10. PubMed ID: 2417112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Tn antigen with Vicia villosa agglutinin in urinary bladder cancer: its relevance to the patient's clinical course.
    Nishiyama T; Matsumoto Y; Watanabe H; Fujiwara M; Sato S
    J Natl Cancer Inst; 1987 Jun; 78(6):1113-8. PubMed ID: 3295352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two different glycosyltransferase defects that result in GalNAc alpha-O-peptide (Tn) expression.
    King MJ; Chan A; Roe R; Warren BF; Dell A; Morris HR; Bartolo DC; Durdey P; Corfield AP
    Glycobiology; 1994 Jun; 4(3):267-79. PubMed ID: 7949653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lectinochemical studies on the glyco-recognition factors of a Tn (GalNAcalpha1-->Ser/Thr) specific lectin isolated from the seeds of Salvia sclarea.
    Wu AM
    J Biomed Sci; 2005; 12(1):167-84. PubMed ID: 15864748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosynthesis of O-glycans in leukocytes from normal donors and from patients with leukemia: increase in O-glycan core 2 UDP-GlcNAc:Gal beta 3 GalNAc alpha-R (GlcNAc to GalNAc) beta(1-6)-N-acetylglucosaminyltransferase in leukemic cells.
    Brockhausen I; Kuhns W; Schachter H; Matta KL; Sutherland DR; Baker MA
    Cancer Res; 1991 Feb; 51(4):1257-63. PubMed ID: 1997166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.